Seeing Is Believing

Currently out of the existing stock ratings of Mara Goldstein, 133 are a BUY (74.72%), 43 are a HOLD (24.16%), 2 are a SELL (1.12%).
Analyst Mara Goldstein, currently employed at MIZUHO, carries an average stock price target met ratio of 48.17% that have a potential upside of 45.66% achieved within 279 days.
Mara Goldstein’s has documented 339 price targets and ratings displayed on 39 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on INCY, yte at 04-Nov-2025.
Analyst best performing recommendations are on FTSV (FORTY SEVEN).
The best stock recommendation documented was for CRVS (CORVUS PHARMACEUTICALS) at 3/30/2023. The price target of $3.5 was fulfilled within 69 days with a profit of $2.71 (343.04%) receiving and performance score of 49.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Nov-2019
$101
$-7.24 (-6.69%)
$101
6 years 4 months 15 days ago
(01-Nov-2019)
2/8 (25%)
$-7.53 (-6.94%)
171
Hold Since 26-Oct-2018
$115
$6.76 (6.25%)
$102
6 years 4 months 15 days ago
(01-Nov-2019)
3/12 (25%)
$6.47 (5.96%)
382
Hold Since 01-Nov-2019
$102
6 years 4 months 15 days ago
(01-Nov-2019)
1/1 (100%)
$18.78 (22.57%)
322
Hold Since 19-Aug-2019
$100
$-8.24 (-7.61%)
$128
6 years 6 months 25 days ago
(19-Aug-2019)
3/6 (50%)
$4.78 (5.02%)
159
Buy Since 13-Feb-2018
$102
$-6.24 (-5.76%)
$105
6 years 10 months 13 days ago
(03-May-2019)
4/4 (100%)
$5.12 (5.28%)
207
Which stock is Mara Goldstein is most bullish on?
Which stock is Mara Goldstein is most reserved on?
What Year was the first public recommendation made by Mara Goldstein?